Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Differentiation of human embryonic stem cells

A technology of cell differentiation and pluripotent stem cells, applied to embryonic cells, non-embryonic pluripotent stem cells, artificial cell constructs, etc., can solve problems such as simulating the developmental program of higher mammals

Inactive Publication Date: 2010-10-13
LIFESCAN INC
View PDF39 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0015] However, mouse embryonic stem cell developmental models may not accurately mimic the developmental program of higher mammals such as humans

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Differentiation of human embryonic stem cells
  • Differentiation of human embryonic stem cells
  • Differentiation of human embryonic stem cells

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0349] Human embryonic stem cell culture

[0350] Human embryonic stem cell lines H1, H7, and H9 were obtained from WiCell Research Institute, Inc., (Madison, WI) and cultured according to instructions provided by the source institution. Briefly, cells were cultured on mouse embryonic fibroblast (MEF) feeder layers in ES cell culture medium supplemented with 20% Knockout serum replacer, 100 nM of MEM non-essential amino acids, 0.5 mM β-mercaptoethanol, 2 mM L-glutamine and 4 ng / ml human basic fibroblast growth factor (bFGF) (all from Invitrogen / GIBCO) in DMEM / F12 (Invitrogen / GIBCO). MEF cells derived from E13 to 13.5 mouse embryos were purchased from Charles River. MEF cells were expanded in DMEM medium supplemented with 10% FBS (Hyclone), 2 mM glutamine and 100 mM of MEM non-essential amino acids. Subconfluent MEF cell cultures were treated with 10 mg / ml mitomycin C (Sigma (St.Louis, MO)) for 3 hours to prevent cell division, and then trypsinized and treated with 2 × 10 ...

example 2

[0352] Formation of definitive endoderm

[0353] The effect of activin A on the expression of definitive endoderm markers was detected. Activin A (100 ng / ml) was added to human embryonic stem cell populations cultured on mouse embryonic fibroblasts. Cells were continuously cultured in the presence of Activin A and harvested at the indicated times. By PCR ( figure 1 ), FACS (results are summarized in Table II) and immunohistochemistry ( figure 2 ) to detect the expression levels of definitive endoderm markers.

[0354] Activin A caused a time-dependent increase in the expression of CXCR4, GATA4, HNF-3β, Mixl1 and Sox-17 mRNA in the H9 cell line ( figure 1 , screen a). Significant upregulation of the anterior endoderm markers Cerberus, Otx-1 and Hex genes was also observed ( figure 1, screen b). After treatment with Activin A, an increase in CXCR4 protein was observed by FACS analysis. The expression of E-cadherin and N-cadherin was not altered after treatment with Ac...

example 3

[0356] Pancreatic endoderm formation

[0357] Growth factors known to induce differentiation of human embryonic stem cells into pancreatic endoderm are added to the cell culture. Specifically, activin A, bFGF and retinoic acid, known to induce pancreatic endoderm formation, were added to the cell cultures.

[0358] In the first series of experiments, activin A was added to populations of human embryonic stem cells in DMEM / F12 supplemented with 0% to 2% serum and activin A (100ng / ml) to induce fibroblasts in mouse embryos. Cells were cultured for up to seven days. exist image 3 Cells were harvested at the indicated time points and analyzed by PCR for the expression of the indicated genes ( image 3 , Figure 4 and Figure 5 ). exist image 3 , PCR analysis revealed that cells treated with activin expressed a broad spectrum of genes associated with endoderm development, including GATA4 ( image 3 , panel a), Sox-17 ( image 3 , panel b), HNF-3β ( image 3 , panel c)...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides methods to promote the differentiation of pluripotent stem cells. In particular, the present invention provides an improved method for the formation of pancreatic endoderm, pancreatic hormone expressing cells and pancreatic hormone secreting cells. The present invention also provides methods to promote the differentiation of pluripotent stem cells without the use of a feeder cell layer.

Description

technical field [0001] This patent application is a continuation-in-part of U.S. Patent Application No. 11 / 736,908, filed April 18, 2007, which claims U.S. Provisional Application No. 60 / 745,899, filed April 28, 2006, filed September 30, 2006 Priority to U.S. Provisional Application No. 60 / 827,695, filed December 29, 2006, and U.S. Provisional Application No. 60 / 882,670, filed December 29, 2006, the entire contents of which are incorporated herein by reference. [0002] The present invention provides methods for promoting differentiation of pluripotent stem cells. In particular, the present invention provides improved methods of forming pancreatic endoderm, pancreatic hormone expressing cells, and pancreatic hormone secreting cells. The present invention also provides methods of promoting differentiation of pluripotent stem cells without the use of a feeder cell layer. Background technique [0003] Due to advances in cell replacement therapy for type 1 diabetes and insuffi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N5/08C12N5/071C12N5/074
CPCC12N5/0678C12N2501/115C12N2501/23C12N2501/415C12N2501/16C12N5/0606C12N2533/52C12N2501/119C12N5/067C12N2501/70C12N2501/155C12N2506/02C12N2533/90C12N2501/385C12N2502/13C12N5/0676A61P1/18A61P3/10A61P5/50
Inventor A·雷扎尼亚
Owner LIFESCAN INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com